As reported in New England Journal of Medicine (Oct 30, 2008), DiamydŽ preserves insulin producing beta cells best in patients recently diagnosed with the disease. Beta cell destruction is a consecutive process, eventually leading to the need for life-long treatment with insulin. DiamydŽ given before clinical presentation could hence prevent the onset of the disease.
Del Global Technologies Corp. (OTCBB: DGTC) ("Del Global" or "the Company") announced that it will sell and market the TITAN digital radiographic product line. Del Medical will feature the TITAN digital radiographic imaging systems at booth # 4234 at the RSNA 2008 Annual Meeting and Exposition, which is being held November 30 - December 5, 2008 in Chicago, IL.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.